Article
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive-06-01-2001Volume0 Issue 0
Stocks: Catching the Market Blues
Author(s):
Buckinghamshire, UK-The pharma industry may be countercyclical, but it’s not immune to market trends. Nycomed Amersham recently postponed a partial US stock flotation of its life sciences company, ABBiotech, because of market weakness.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Videos
Related Content
